Becker's Healthcare July 23, 2024
In recent years, more prescriptions for GLP-1 drugs were written to treat obesity than Type 2 diabetes, adding to accessibility and shortage concerns, according to a study published July 23 in Annals of Internal Medicine.
Researchers from Los Angeles-based Cedars-Sinai and the University of Pennsylvania in Philadelphia used a nationwide database to analyze the medical records of 45 million individuals with at least one outpatient or inpatient visit from 2011-23. They found about 1 million new GLP-1 users during this time, and classified them based on whether they had diabetes, obesity or other related conditions.
Here’s a breakdown of the shifts researchers observed:
- An average of nearly 65% of GLP-1 users had Type 2 diabetes between...
Today's Sponsors
Today's Sponsor